{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:33:22Z","timestamp":1793424802813,"version":"4.5.0"},"reference-count":41,"publisher":"Medical Association of Nippon Medical School","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2026,10,20]]},"DOI":"10.1272\/jnms.jnms.2026_93-501","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T22:07:20Z","timestamp":1763330840000},"page":"402-407","source":"Crossref","is-referenced-by-count":0,"title":["Leptomeningeal Metastasis from Colorectal Cancer Treated with Folinic Acid, Fluorouracil, and Oxaliplatin Chemotherapy Plus Bevacizumab: A Case Report"],"prefix":"10.1272","volume":"93","author":[{"given":"Tomohiro","family":"Hayakawa","sequence":"first","affiliation":[{"name":"Department of Surgery, Hasuda Hospital"},{"name":"Department of Surgery, Kamisu Saiseikai Hospital"},{"name":"Department of Gastrointestinal Hepato-Biliary-Pancreatic Surgery, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kamisu Saiseikai Hospital"},{"name":"Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kamisu Saiseikai Hospital"},{"name":"Department of Gastrointestinal Hepato-Biliary-Pancreatic Surgery, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goro","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Hepato-Biliary-Pancreatic Surgery, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsutani","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Nippon Medical School Musashikosugi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Hepato-Biliary-Pancreatic Surgery, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Giglio P, Weinberg JS, Forman AD, Wolff R, Groves MD. Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract. Cancer. 2005 Jun 1;103 (11):2355\u201362.","DOI":"10.1002\/cncr.21082"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Chamberlain MC. Leptomeningeal metastasis. Curr Opin Oncol. 2010 Nov;22 (6):627\u201335.","DOI":"10.1097\/CCO.0b013e32833de986"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Le Rhun E, Galanis E. Leptomeningeal metastases of solid cancer. Curr Opin Neurol. 2016 Dec;29 (6):797\u2013805.","DOI":"10.1097\/WCO.0000000000000393"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wang N, Bertalan MS, Brastianos PK. Leptomeningeal metastasis from systemic cancer: review and update on management. Cancer. 2018 Jan 1;124 (1):21\u201335.","DOI":"10.1002\/cncr.30911"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Thakkar JP, Kumthekar P, Dixit KS, Stupp R, Lukas RV. Leptomeningeal metastasis from solid tumors. J Neurol Sci. 2020 Apr 15;411:116706.","DOI":"10.1016\/j.jns.2020.116706"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Glitza IC, Smalley KSM, Brastianos PK, et al. Leptomeningeal disease in melanoma patients: an update to treatment, challenges, and future directions. Pigment Cell Melanoma Res. 2020 Jul;33 (4):527\u201341.","DOI":"10.1111\/pcmr.12861"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Marinova AM, Reilly JL, Wong V, Weiss S, Olszanski AJ. Metastatic melanoma with leptomeningeal disease. J Adv Pract Oncol. 2021 Jan-Feb;12 (1):79\u201383.","DOI":"10.6004\/jadpro.2021.12.1.6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cheng H, Perez-Soler R. Leptomeningeal metastases in non-small-cell lung cancer. Lancet Oncol. 2018 Jan;19 (1):e43\u201355.","DOI":"10.1016\/S1470-2045(17)30689-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Patil S, Rathnum KK. Management of leptomeningeal metastases in non-small cell lung cancer. Indian J Cancer. 2019 Nov;56 (Supplement):S1\u20139.","DOI":"10.4103\/ijc.IJC_74_19"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Wu YL, Zhao Q, Deng L, et al. Leptomeningeal metastasis after effective first-generation EGFR TKI treatment of advanced non-small cell lung cancer. Lung Cancer. 2019 Jan;127:1\u20135.","DOI":"10.1016\/j.lungcan.2018.11.022"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Assi HI, Mahmoud T, Saadeh FS, El Darsa H. Management of leptomeningeal metastasis in breast cancer. Clin Neurol Neurosurg. 2018 Sep;172:151\u20139.","DOI":"10.1016\/j.clineuro.2018.07.001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Franzoi MA, Hortobagyi GN. Leptomeningeal carcinomatosis in patients with breast cancer. Crit Rev Oncol Hematol. 2019 Mar;135:85\u201394.","DOI":"10.1016\/j.critrevonc.2019.01.020"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nagashima T, Muroi K, Kunitama M, et al. Colon cancer with meningeal carcinomatosis and myelodysplastic syndrome in a patient who underwent intensive chemotherapy for acute myelogenous leukemia: a case report. Jpn J Clin Oncol. 2001 May;31 (5):221\u20135.","DOI":"10.1093\/jjco\/hye041"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sartore-Bianchi A, Pedrazzoli P, Ponchio L, Lanza A, Pavesi L. Meningeal carcinomatosis in rectal cancer. Clin Oncol (R Coll Radiol). 2002 Feb;14 (1):82.","DOI":"10.1053\/clon.2001.0017"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Suzuki T, Sakaguchi H, Yamamoto S, Hisa Y. Sudden hearing loss due to meningeal carcinomatosis from rectal carcinoma. Auris Nasus Larynx. 2006 Sept;33 (3):315\u20139.","DOI":"10.1016\/j.anl.2005.11.010"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Longo R, Morabito A, Carillio G, et al. Multiorganic dissemination of a colorectal signet ring cell carcinoma with fulminant clinical course. Int J Gastrointest Cancer. 2006;37 (1):49\u201354.","DOI":"10.1385\/IJGC:37:1:49"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chadha MK, Iyer R, Nava ME, Abdelhalim A, Gibbs JF. Leptomeningeal metastases from signet ring adenocarcinoma of the cecum. J Clin Oncol. 2007 Nov 1;25 (31):5028\u20139.","DOI":"10.1200\/JCO.2007.13.3470"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Crncevic-Urek M, Bokun T, Kujundzic M, et al. Leptomeninges as the first and only dissemination site of colorectal cancer. Int J Colorectal Dis. 2009 Mar;24 (3):355\u20136.","DOI":"10.1007\/s00384-008-0560-7"},{"key":"19","unstructured":"19. Bruce BB, Tehrani M, Newman NJ, Biousse V. Deafness and blindness as a presentation of colorectal meningeal carcinomatosis. Clin Adv Hematol Oncol. 2010 Aug;8 (8):564\u20136."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yildirim Y, Akcali Z, Ozyilkan O. Signet-ring cell carcinoma of the colon with leptomeningeal involvement. J Clin Neurosci. 2010 Aug;17 (8):1051\u20133.","DOI":"10.1016\/j.jocn.2009.10.014"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lahiri RP, Burnand KM, Bandi A, Farooq N, Sathesh-Kumar T. Colorectal cancer presenting with dysarthria and ataxia: a case of isolated leptomeningeal metastasis. Ann R Coll Surg Engl. 2011 Oct;93 (7):e133\u20135.","DOI":"10.1308\/147870811X602104"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kato Y, Takeda H, Dembo T, Fukuoka T, Tanahashi N. Progressive multiple cranial nerve palsies as the presenting symptom of meningeal carcinomatosis from occult colon adenocarcinoma. Intern Med. 2012;51 (7):795\u20137.","DOI":"10.2169\/internalmedicine.51.6682"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kleinfeld K, Peters WH, Stephenson C, Azar NJ. Leptomeningeal metastasis from occult signet-ring cell colon adenocarcinoma presenting with isolated headache. J Clin Neurosci. 2013 Jun;20 (6):890\u20132.","DOI":"10.1016\/j.jocn.2012.05.047"},{"key":"24","unstructured":"24. Mohebi N, Moghaddasi M, Karimian H. Diffuse leptomeningeal metastasis from signet-ring cell adenocarcinoma of the sigmoid. J Case Rep Pract. 2014;2 (1):34\u20136."},{"key":"25","unstructured":"25. Assi R, Hamieh L, Mukherji D, et al. Leptomeningeal metastasis as initial manifestation of signet ring colorectal adenocarcinoma: a case report with review of literature. J Gastrointest Oncol. 2015 Dec;6 (6):E89\u2013E101."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Lusilla A, de Tomas J. Leptomeningeal carcinomatosis in a young patient with obstructive colorectal signet- ring cell adenocarcinoma. Rev Esp Enferm Dig. 2017 Jul;109 (7):535.","DOI":"10.17235\/reed.2017.4602\/2016"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Zeeneldin A, Al-Dhaibani N, Saleh YM, et al. Anorectal cancer with bone marrow and leptomeningeal metastases. Case Rep Oncol Med. 2018 Dec 30;2018:9246139.","DOI":"10.1155\/2018\/9246139"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Smilde BJ, Louwerenburg AF, van Santen MM, Hendriks MP. Leptomeningeal metastases from colorectal signet-ring cell cancer: a case report and literature review. Clin Colorectal Cancer. 2022 Jun;21 (2):167\u20139.","DOI":"10.1016\/j.clcc.2021.11.007"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Taylor G, Karlin N, Halfdanarson TR, Coppola K, Grothey A. Leptomeningeal carcinomatosis in colorectal cancer: the Mayo Clinic experience. Clin Colorectal Cancer. 2018 Jun;17 (2):e183\u20137.","DOI":"10.1016\/j.clcc.2017.11.003"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Nitsche U, Zimmermann A, Spath C, et al. Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis. Ann Surg. 2013 Nov;258 (5):775\u201382; discussion 782-3.","DOI":"10.1097\/SLA.0b013e3182a69f7e"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Alvi MA, Loughrey MB, Dunne P, et al. Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies. Br J Cancer. 2017 Jul 11;117 (2):203\u20139.","DOI":"10.1038\/bjc.2017.168"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. An Y, Zhou J, Lin G, et al. Clinicopathological and molecular characteristics of colorectal signet ring cell carcinoma: a review. Pathol Oncol Res. 2021 Jul 26;27:1609859.","DOI":"10.3389\/pore.2021.1609859"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Puccini A, Poorman K, Catalano F, et al. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets. Oncogene. 2022 Jun;41 (26):3455\u201360.","DOI":"10.1038\/s41388-022-02350-6"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kato H, Emura S, Takashima T, Ohmori K, Sunaga T. Gadolinium-enhanced magnetic resonance imaging of meningeal carcinomatosis in colon cancer. Tohoku J Exp Med. 1995 Jun;176 (2):121\u20136.","DOI":"10.1620\/tjem.176.121"},{"key":"35","unstructured":"35. Chamberlain M, Junck L, Brandsma D, et al. Leptomeningeal metastases: a RANO proposal for response criteria. Neuro Oncol. 2017 Apr 1;19 (4):484\u201392."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Le Rhun E, Weller M, Brandsma D, et al. EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Ann Oncol. 2017 Jul 1;28 (suppl_4):iv84\u201399.","DOI":"10.1093\/annonc\/mdx221"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Freilich RJ, Krol G, DeAngelis LM. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol. 1995 Jul;38 (1):51\u20137.","DOI":"10.1002\/ana.410380111"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Shinji S, Yamada T, Matsuda A, et al. Recent advances in the treatment of colorectal cancer: a review. J Nippon Med Sch. 2022 Jun 28;89 (3):246\u201354.","DOI":"10.1272\/jnms.JNMS.2022_89-310"},{"key":"39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12885-015-1290-1","volume":"15","author":"PF Wu","year":"2015","unstructured":"39. Wu PF, Lin CH, Kuo CH, et al. A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis. BMC Cancer. 2015 Apr 17;15:299.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Yamada Y, Yoshimatsu K, Yokomizo H, et al. Capecitabine plus bevacizumab as first-line therapy for patients with metastatic colorectal cancer and poor performance status. J Nippon Med Sch. 2021 Nov 17;88 (5):496\u20139.","DOI":"10.1272\/jnms.JNMS.2021_88-415"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Cremolini C, Antoniotti C, Stein A, et al. Individual patient data meta-analysis of FOLFOXIRI plus bevacizumab versus doublets plus bevacizumab as initial therapy of unresectable metastatic colorectal cancer. J Clin Oncol. 2020 Aug 20;JCO2001225.","DOI":"10.1200\/JCO.20.01225"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/5\/93_JNMS.2026_93-501\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:11:15Z","timestamp":1793423475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/5\/93_JNMS.2026_93-501\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2026_93-501","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"article-number":"JNMS.2026_93-501"}}